Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
- Mistik, Resit
- Hakyemez, Ismail Necati
- KARAKEÇİLİ, FARUK
- Cetinkaya, Riza Aytac
- Cagatay, Atahan
- DEMİR, NAZLIM AKTUĞ
- Tuna, Nazan
- Simsek, Sumeyra
- Guzel, Deniz Kamalak
- Turkoglu, Emine
- YILDIZ, ORHAN
- Tarakci, Huseyin
- Tulek, Necla
- Gurbuz, Yunus
- Bilgin, Huseyin
- Turker, Nesrin
- Kinikli, Sami
- İNAN, DİLARA
- ERSÖZ, GÜLDEN
- Simsek, Funda
- Batirel, Ayse
- URAL, ONUR
- Barut, Sener
- AKHAN, SILA
- Ertem, Gunay Tuncer
- Celik, Ilhami
- AYGEN, BİLGEHAN
- Demirturk, Nese
- Dogan, Nurhan
- SALTOĞLU, Neşe
- Asan, Ali
- Konya, Petek
- ÇELEN, MUSTAFA KEMAL
- Suer, Kaya
- Ozturk, Sinan
- Ozel, Selcan Arslan
- Sener, Alper
- Kuruuzum, Ziya
- SİLİ, ULUHAN
- KORKMAZ, PINAR
- Ormen, Bahar
Publication date
February 2021
DOIAbstract
Background: In this study, we aimed to investigate the efficacy and safety of sofosbuvir-based therapies in the treatment of chronic hepatitis C in real-world clinical practice
Add to ORKG